Thistle extract cut a key liver enzyme by a wide margin in a meta-analysis of 2,283 NAFLD patients — but came with a catch.
- 2025-08-01
- Meta-Analysis
- n = 2,283
- Asia Pacific journal of clinical nutrition
This meta-analysis offers the first solid evidence that silymarin from thistle can sharply reduce AST levels in people with fatty liver disease, but the moderate strength of the evidence (8 studies, 5 beneficial) and the risk of gastrointestinal side effects mean the picture is promising, not proven.